Jiangtao Lin

4.0k total citations · 1 hit paper
106 papers, 1.9k citations indexed

About

Jiangtao Lin is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Emergency Medical Services. According to data from OpenAlex, Jiangtao Lin has authored 106 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Pulmonary and Respiratory Medicine, 64 papers in Physiology and 17 papers in Emergency Medical Services. Recurrent topics in Jiangtao Lin's work include Asthma and respiratory diseases (63 papers), Respiratory and Cough-Related Research (39 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (27 papers). Jiangtao Lin is often cited by papers focused on Asthma and respiratory diseases (63 papers), Respiratory and Cough-Related Research (39 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (27 papers). Jiangtao Lin collaborates with scholars based in China, United States and Japan. Jiangtao Lin's co-authors include Xin Zhou, Tengfei Zhao, Linlin Wang, Caihua Zhang, Liwei Ying, Kan Xu, Shining Xiao, Jingkai Wang, Chenggui Wang and Chunxiao Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Jiangtao Lin

100 papers receiving 1.9k citations

Hit Papers

Gelatin Methacrylate (GelMA)-Based Hydrogels for Cell Tra... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiangtao Lin China 20 1.0k 968 222 178 141 106 1.9k
Petros Bakakos Greece 23 996 1.0× 1.1k 1.1× 87 0.4× 197 1.1× 136 1.0× 138 1.8k
María Jesús Cruz Spain 27 725 0.7× 1.5k 1.6× 82 0.4× 150 0.8× 124 0.9× 180 2.7k
Han‐Pin Kuo Taiwan 18 369 0.4× 488 0.5× 73 0.3× 206 1.2× 125 0.9× 71 1.3k
Timm Greulich Germany 24 489 0.5× 772 0.8× 149 0.7× 336 1.9× 61 0.4× 97 1.7k
Michelle L. Hernandez United States 24 456 0.4× 319 0.3× 37 0.2× 196 1.1× 102 0.7× 85 1.6k
David A. Rubenstein United States 24 387 0.4× 201 0.2× 173 0.8× 255 1.4× 325 2.3× 86 1.8k
Elina Toskala United States 25 813 0.8× 441 0.5× 36 0.2× 198 1.1× 384 2.7× 98 1.9k
Sven Seys Belgium 35 1.6k 1.5× 968 1.0× 59 0.3× 338 1.9× 490 3.5× 86 3.2k
Horng‐Chyuan Lin Taiwan 20 225 0.2× 550 0.6× 46 0.2× 85 0.5× 148 1.0× 60 1.1k

Countries citing papers authored by Jiangtao Lin

Since Specialization
Citations

This map shows the geographic impact of Jiangtao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangtao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangtao Lin more than expected).

Fields of papers citing papers by Jiangtao Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangtao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangtao Lin. The network helps show where Jiangtao Lin may publish in the future.

Co-authorship network of co-authors of Jiangtao Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangtao Lin. A scholar is included among the top collaborators of Jiangtao Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangtao Lin. Jiangtao Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Xin, et al.. (2024). Bronchial thermoplasty for severe asthma: potential mechanisms and response markers. Therapeutic Advances in Respiratory Disease. 18. 2693845676–2693845676.
2.
Lin, Jiangtao, et al.. (2024). User Mapping and Radio Resource Management in Demand-based GEO Satellite Systems. 1–6. 1 indexed citations
4.
Hou, Xin, et al.. (2023). Xingbei antitussive granules ameliorate cough hypersensitivity in post-infectious cough guinea pigs by regulating tryptase/PAR2/TRPV1 pathway. Journal of Ethnopharmacology. 319(Pt 3). 117243–117243. 5 indexed citations
5.
Zhang, Jingyuan & Jiangtao Lin. (2023). Efficacy of artesunate in asthma: based on network pharmacology and molecular docking. Journal of Thoracic Disease. 15(4). 1658–1674. 3 indexed citations
6.
Zhang, Mengyuan, et al.. (2023). Artesunate inhibits airway remodeling in asthma via the MAPK signaling pathway. Frontiers in Pharmacology. 14. 1145188–1145188. 12 indexed citations
7.
Zhang, Qing, et al.. (2023). Role of clinical biomarkers in predicting the effectiveness of omalizumab. Therapeutic Advances in Respiratory Disease. 17. 2683750149–2683750149. 2 indexed citations
8.
Li, Yun, et al.. (2022). Artesunate: A review of its therapeutic insights in respiratory diseases. Phytomedicine. 104. 154259–154259. 43 indexed citations
9.
Zhang, Qing, Hongwen Li, Jingru Wang, et al.. (2021). CD3E as a new predictive biomarker of response to omalizumab treatment in asthma patients: Evidence from bioinformatic analysis. International Immunopharmacology. 93. 107423–107423. 8 indexed citations
10.
Lin, Jiangtao, et al.. (2020). Analysis of the Mechanism of Zhichuanling Oral Liquid in Treating Bronchial Asthma Based on Network Pharmacology. Evidence-based Complementary and Alternative Medicine. 2020(1). 1875980–1875980. 14 indexed citations
11.
Lin, Jiangtao, et al.. (2020). Puzzling onsets of pneumonia sequentially after each session of bronchial thermoplasty: a case report. BMC Pulmonary Medicine. 20(1). 211–211.
12.
Lu, Peng, Yongming Zhang, Jiangtao Lin, et al.. (2019). Multi-city study on air pollution and hospital outpatient visits for asthma in China. Environmental Pollution. 257. 113638–113638. 51 indexed citations
13.
Lin, Jiangtao, Xin Zhou, Changzheng Wang, et al.. (2018). Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines. Expert Review of Respiratory Medicine. 12(3). 191–202. 10 indexed citations
14.
Lin, Jiangtao, Chuntao Liu, Jian Kang, et al.. (2017). Comparison of fluticasone propionate with budesonide administered via nebulizer: a randomized controlled trial in patients with severe persistent asthma. Journal of Thoracic Disease. 9(2). 372–385. 3 indexed citations
15.
Su, Nan, Jiangtao Lin, Kai Yin, et al.. (2016). [A cross-section study of severe asthma in eight provinces of China].. PubMed. 55(12). 917–921. 8 indexed citations
16.
Price, David, Aileen David-Wang, Sang‐Heon Cho, et al.. (2016). Asthma in Asia: Physician perspectives on control, inhaler use and patient communications. Journal of Asthma. 53(7). 761–769. 19 indexed citations
17.
Su, Nan, Jiangtao Lin, Jing Li, et al.. (2014). Evaluation of asthma control: a questionnaire-based survey in China. Chinese Medical Journal. 127(11). 2030–2036. 4 indexed citations
18.
Zhou, Xin, Fengming Ding, Jiangtao Lin, et al.. (2007). Validity of Asthma Control Test in Chinese patients. Chinese Medical Journal. 120(12). 1037–1041. 39 indexed citations
19.
Suzuki, Takehiro, et al.. (1996). Aerosolized Human Neutrophil Elastase Induces Airway Constriction and Hyperresponsiveness With Protection by Intravenous Pretreatment With Half-Length Secretory Leukoprotease Inhibitor. American Journal of Respiratory and Critical Care Medicine. 153(4). 1405–1411. 73 indexed citations
20.
Okayama, Michiko, et al.. (1994). Effect of Pilocarpine on Propranolol-Induced Bronchoconstriction in Asthma. American Journal of Respiratory and Critical Care Medicine. 149(1). 76–80. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026